Page:Special 301 Report 2011.pdf/41

 inadequate enforcement efforts, and a failure to provide additional training for judges who preside over IPR matters. In addition, Egypt should clarify its commitment to protect against unfair commercial use, as well as unauthorized disclosure, of undisclosed test and other data generated to obtain marketing approval for pharmaceutical products, and to provide an effective system to address patent issues expeditiously in connection with applications to market pharmaceutical products. The United States looks forward to engaging with Egyptian officials at the appropriate time on these and other matters.

Finland

Finland remains on the Watch List. The United States continues to be concerned about the lack of product patent protection for certain pharmaceutical products. U.S. industry continues to express concern that the regulatory framework in Finland regarding process patents filed before 1995, and pending in 1996, denies adequate protection to many of the top-selling U.S. pharmaceutical products currently on the Finnish market. The United States will continue to work with Finland to address this and other matters.

Greece

Greece remains on the Watch List. Greece made some progress in 2010, including by creating a Special IP Protection Department within its tax police, establishing special IPR courts, and by creating two new IPR divisions within the Ministry of Finance's Financial Crime Prosecution Agency. In addition, Greece amended its copyright law to provide for administrative fines against shops that sell illegal sound recordings. While the United States appreciates the impact of the financial crisis on various initiatives, the United States is concerned that steps that Greece took to improve the coordination of enforcement efforts did not continue in 2010 and that enforcement efforts remain weak. Greece has also made only incremental progress in implementing its 2009 IPR action plan. The United States urges Greece to take more sustained action against IPR infringement and ensure that the appropriate tools are available to address counterfeiting and piracy. The United States will continue to work with Greece to address these and other issues.

Guatemala

Guatemala remains on the Watch List. Guatemala continues to improve its IPR enforcement framework. The new IPR prosecutor has worked to improve enforcement efforts by increasing the number of investigations, issuing more fines, securing more convictions for IPR violations, and seizing a significant amount of pirated and counterfeit products. In addition, the interagency IPR working group has focused its efforts on the training of judges and officials, including training aimed at identifying and preserving evidence of counterfeit medications. Training efforts have also led to improved cooperation between the IPR prosecutor, enforcement agencies, and rights holders. However, piracy and counterfeiting remain widespread, and concerns remain that the resources available for enforcement activities may be inadequate. The United States encourages Guatemala to continue its efforts, despite recent budget cuts, and to focus its enforcement efforts against manufacturers of pirated and counterfeit goods. The United States looks forward to continuing engagement with Guatemala on these and other matters and will monitor Guatemala's implementation of its commitments under CAFTA-DR.